Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00599820Phase 3Terminated
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
Angioid StreaksChoroidal Neovascularization
PrincipalinvestigatorStart date: 2005-11-01
NCT00417716Phase 3Withdrawn
Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
Diabetes Mellitus Type 2Diabetic Macular Edema
PrincipalinvestigatorStart date: 2005-09-01

Research Network

Collaboration Network

11 collaborators·34 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Asociación para Evitar la Ceguera en México

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Griselda Alvarez-Rivera, MD

Asociación para Evitar la Ceguera en México

Moderately Similar
2 trials

Shared therapeutic areas:

Angioid StreaksChoroidal NeovascularizationDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 2 trials
Similarity Score48%

Hugo Quiroz-Mercado, MD

Asociación para Evitar la Ceguera en México

Moderately Similar
8 trials

Shared therapeutic areas:

Angioid StreaksChoroidal NeovascularizationDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 2 trials
Similarity Score48%

Myriam Hernández-Rojas, MD

Asociación para Evitar la Ceguera en México

Moderately Similar
2 trials

Shared therapeutic areas:

Angioid StreaksChoroidal NeovascularizationDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 2 trials
Similarity Score48%

Jans Fromow-Guerra, MD PhD

Asociación para Evitar la Ceguera en México

Moderately Similar
2 trials

Shared therapeutic areas:

Angioid StreaksChoroidal NeovascularizationDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 2 trials
Similarity Score48%

Juan M Jiménez-Sierra, MD

Asociación para Evitar la Ceguera en México

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetic Macular Edema

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score24%

Elizabeth Reyna-Castelán

Asociación para Evitar la Ceguera en México

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetic Macular Edema

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score24%

Elizabeth Reyna-Castelán, MD

Asociación para Evitar la Ceguera en México

Related
1 trials

Shared therapeutic areas:

Angioid StreaksChoroidal Neovascularization

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score24%

Mariana Martínez-Castellanos, MD

Asociación para Evitar la Ceguera en México

Related
1 trials

Shared therapeutic areas:

Angioid StreaksChoroidal Neovascularization

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score24%

İsmail ÖZSOY, Assoc. Prof. Dr.

Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye

Related
10 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score8%

Paolo Bonato, PhD

Spaulding Rehabilitation Hospital

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00599820Phase 3PrincipalInvestigator

Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Angioid StreaksChoroidal Neovascularization
Terminated
NCT00417716Phase 3PrincipalInvestigator

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

Diabetes Mellitus Type 2Diabetic Macular Edema
Withdrawn

All 2 trials loaded